
THERAPEUTIC VITRECTOMY AS AN ADJUNCT TREATMENT TO SYSTEMIC CHEMOTHERAPY FOR INTRAOCULAR LYMPHOMA
Author(s) -
Gregory J. Bever,
Dan J. Kim,
Armin R. Afshar,
James L. Rubenstein,
Bertil Damato
Publication year - 2020
Publication title -
retinal cases and brief reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 14
eISSN - 1937-1578
pISSN - 1935-1089
DOI - 10.1097/icb.0000000000000668
Subject(s) - medicine , vitrectomy , intraocular lymphoma , lymphoma , chemotherapy , adjunct , disease , eye disease , ophthalmology , surgery , visual acuity , linguistics , philosophy
To report the outcome of a previously vitrectomized eye having less lymphoma disease burden compared with the contralateral nonvitrectomized eye over the course of 3.5 years while on systemic chemotherapy.